These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 27098274)

  • 1. MicroRNA and gynecologic cancers.
    Kanekura K; Nishi H; Isaka K; Kuroda M
    J Obstet Gynaecol Res; 2016 Jun; 42(6):612-7. PubMed ID: 27098274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of microRNAs in cancers of the female reproductive tract: insights from recent clinical and experimental discovery studies.
    Logan M; Hawkins SM
    Clin Sci (Lond); 2015 Feb; 128(3):153-80. PubMed ID: 25294164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating tumor markers in gynecological tumors.
    Rustin GJ
    Curr Opin Oncol; 1996 Sep; 8(5):426-31. PubMed ID: 8914810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetics of gynecologic cancer.
    Whang JD; Lee JH
    J Korean Med Sci; 1997 Oct; 12(5):383-9. PubMed ID: 9364294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular diagnosis and prognosis in gynecologic oncology.
    Silverberg SG
    Arch Pathol Lab Med; 1999 Nov; 123(11):1035-40. PubMed ID: 10539903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International Gynecologic Cancer Society (IGCS) 2016: Meeting report.
    Del Carmen MG; Rice LW
    Gynecol Oncol; 2017 Jan; 144(1):11-15. PubMed ID: 27847107
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of PET in gynecologic malignancy.
    Grigsby PW
    Curr Opin Oncol; 2009 Sep; 21(5):420-4. PubMed ID: 19553814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression analysis of mammaglobin A (SCGB2A2) and lipophilin B (SCGB1D2) in more than 300 human tumors and matching normal tissues reveals their co-expression in gynecologic malignancies.
    Zafrakas M; Petschke B; Donner A; Fritzsche F; Kristiansen G; Knüchel R; Dahl E
    BMC Cancer; 2006 Apr; 6():88. PubMed ID: 16603086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular staging of gynecological cancer: What is the future?
    Binder PS; Prat J; Mutch DG
    Best Pract Res Clin Obstet Gynaecol; 2015 Aug; 29(6):776-89. PubMed ID: 25934522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular genetics of gyn malignancies.
    Taylor RR; Teneriello MG; Nash JD; Park RC; Birrer MJ
    Oncology (Williston Park); 1994 Oct; 8(10):63-70, 73; discussion 73, 78-82. PubMed ID: 7803216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular urinary microRNAs as non-invasive biomarkers of endometrial and ovarian cancer.
    Hanžek A; Siatka C; Duc AE
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7981-7993. PubMed ID: 36914786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p16 expression in the female genital tract and its value in diagnosis.
    O'Neill CJ; McCluggage WG
    Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Office screening for gynecologic cancer.
    Zweizig SL
    Clin Obstet Gynecol; 1999 Jun; 42(2):267-75. PubMed ID: 10370846
    [No Abstract]   [Full Text] [Related]  

  • 14. [Molecular diagnostic techniques in gynaecologic cancer].
    Salvesen HB; Iversen OE; Tropé C
    Tidsskr Nor Laegeforen; 2005 Nov; 125(22):3120-3. PubMed ID: 16299569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt Signaling in Gynecologic Malignancies.
    McMellen A; Woodruff ER; Corr BR; Bitler BG; Moroney MR
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gynecologic malignancies in older women.
    Mirhashemi R; Nieves-Neira W; Averette HE
    Oncology (Williston Park); 2001 May; 15(5):580-6; discussion 592-4, 597-8. PubMed ID: 11396354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations.
    Salani R; Backes FJ; Fung MF; Holschneider CH; Parker LP; Bristow RE; Goff BA
    Am J Obstet Gynecol; 2011 Jun; 204(6):466-78. PubMed ID: 21752752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staging of gynecologic malignancies.
    Ascher SM; Takahama J; Jha RC
    Top Magn Reson Imaging; 2001 Apr; 12(2):105-29. PubMed ID: 11296804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNA and the pathogenesis of ovarian cancer--a new horizon for molecular diagnostics and treatment?
    Kuhlmann JD; Rasch J; Wimberger P; Kasimir-Bauer S
    Clin Chem Lab Med; 2012 Jan; 50(4):601-15. PubMed ID: 22505556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gynecologic cancers.
    Blair AR; Casas CM
    Prim Care; 2009 Mar; 36(1):115-30, ix. PubMed ID: 19231605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.